CONTACT | CLIENT LOGIN | NEWS | IDIFARMA’s facilities built in 2008 were specifically designed for the handling of highly potent substances such as cytotoxics and cytostatics. We have dedicated rooms for these compounds in our formulation and analytical development laboratories, with 100% air renewal, in depression and with the necessary personal protective equipment and other measures in place in order to guarantee the safety of the operators. Also, our GMP plant was conceived from the inception as a high containment area, so we are fully capable of manufacturing highly potent drugs. Before the start of any new development or manufacturing project, we carry out a thorough risk analysis for each active substance, ranking them into one of the 5 operational exposure levels or bands (OEL/OEB classification), as a measure of the concentration in micrograms per cubic meter: In the risk analysis, we take into consideration the specific characteristics of our facilities, and equipment, as well as the necessary personal protective equipment and the specific properties of the active substance. As a general rule, IDIFARMA is able to work with substances in categories 1 to 4, which comprise the overwhelming majority of pharmaceutical active substances. © Idifarma Desarrollo Farmacéutico, S.L. - Pol Mocholi C/ Noáin, 1 - 31110 Noáin (Navarra, Spain) - Tlf +34 948 214 023 - Fax: +34 948 312 359 - info@idifarma.com COMPANY CONTRACT DEVELOPMENT CONTRACT MANUFACTURING FACILITIES TECHNOLOGICAL SOLUTIONS About us Project Management Introduction Layout Introduction History Analytical Development GMP Clinical Batches Analytical Laboratory High Containment Certification Formulation Development GMP Commercial Batches Formulation Laboratory Spray Drying Clients GMP Manufacturing GMP Pilot Plant Film Coating Quality Control Stability Studies Clinical Trial Logistics Regulatory Affairs LEGAL NOTICE | LOCATION | CONTACT FORM | CAREERS | NEWS | CLIENT LOGIN